EBNA-1 sequence variations reflect active EBV replication and disease status or quiescentlatency in lymphocytes

This publication has 20 references indexed in Scilit:

• Epstein-Barr Virus LMP-1 Natural Sequence Variants Differ in Their Potential To Activate Cellular Signaling Pathways
  Journal of Virology, 2001
• Epstein-Barr Viral Load Measurement as a Marker of EBV-related Disease
  Molecular Diagnosis, 2001
• The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
  Journal of General Virology, 1999
• Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: Implications on virus strain selection in malignancy
  International Journal of Cancer, 1999
• The 30‐bp Deletion Variant of Epstein‐Barr Virus‐Encoded Latent Membrane Protein‐1 Prevails in Acute Infectious Mononucleosis
  The Journal of Infectious Diseases, 1997
• Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese
  International Journal of Cancer, 1997
• Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells.
  Journal of General Virology, 1997
• Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma
  Journal of General Virology, 1991
• U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
  Proceedings of the National Academy of Sciences, 1984
• DNA sequence and expression of the B95-8 Epstein—Barr virus genome
  Nature, 1984